Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology:: A population-based, 5-year follow-up study

被引:223
作者
Molano, M
van den Brule, A
Plummer, M
Weiderpass, E
Posso, H
Arslan, A
Meijer, CJLM
Muñoz, N
Franceschi, S
机构
[1] Int Agcy Res Canc, F-69372 Lyon 08, France
[2] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands
[3] Inst Nacl Cancerol, Div Invest, Bogota, Colombia
关键词
cervix neoplasms; cohort studies; cytology; oral contraceptives; papillomavirus;
D O I
10.1093/aje/kwg171
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Little is known about the factors that influence clearance of human papillomavirus (HPV), the primary cause of cervical carcinoma. A total of 227 women cytologically normal and HPV positive at baseline were identified from a population-based cohort of 1,995 Bogota, Colombia, women aged 13-85 years followed between 1993 and 2000 (mean follow-up, 5.3 years). HPV DNA detection and viral load determination were based on a GP5+/GP6+ polymerase chain reaction enzyme immunoassay. Rate ratio estimates for HPV clearance were calculated by using methods for interval-censored survival time data. Analyses were based on 316 type-specific HPV infections. HPV 16 had a significantly lower clearance rate than infections with low-risk types (rate ratio (RR)=0.47, 95% confidence interval (CI): 0.32, 0.72), HPV types related to HPV 16 (types 31, 33, 35, 52, 58) had intermediate clearance rates (RR=0.62, 95% CI: 0.47, 0.94), and other high-risk types did not show evidence of slower clearance compared with low-risk types. Infections with single and multiple HPV types had similar clearance rates. There was no evidence of a dose-response relation between clearance and viral load. Observed was slower clearance in parous women (RR=0.64, 95% CI: 0.47, 0.89) and faster clearance in ever users of oral contraceptives (RR=1.38, 95% CI: 1.07, 1.77).
引用
收藏
页码:486 / 494
页数:9
相关论文
共 61 条
[1]   Human papillomavirus type 18: Association with poor prognosis in early stage cervical cancer [J].
Burger, RA ;
Monk, BJ ;
Kurosaki, T ;
AntonCulver, H ;
Vasilev, SA ;
Berman, ML ;
Wilczynski, SP .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (19) :1361-1368
[2]  
Castle PE, 2002, JNCI-J NATL CANCER I, V94, P1406, DOI 10.1093/jnci/94.18.1406
[3]   Human papillomavirus types in invasive cervical cancer worldwide:: a meta-analysis [J].
Clifford, GM ;
Smith, JS ;
Plummer, M ;
Muñoz, N ;
Franceschi, S .
BRITISH JOURNAL OF CANCER, 2003, 88 (01) :63-73
[4]   Screening for cervical cancer [J].
Cuzick, J ;
Meijer, CJLM ;
Walboomers, JMM .
LANCET, 1998, 351 (9113) :1439-1440
[5]   Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort [J].
Deacon, JM ;
Evans, CD ;
Yule, R ;
Desai, M ;
Binns, W ;
Taylor, C ;
Peto, J .
BRITISH JOURNAL OF CANCER, 2000, 83 (11) :1565-1572
[6]   A population-based five-year follow-up study of cervical human papillomavirus infection [J].
Elfgren, K ;
Kalantari, M ;
Moberger, B ;
Hagmar, B ;
Dillner, J .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 183 (03) :561-567
[7]   THE ASSOCIATION OF AN HPV16 ONCOGENE VARIANT WITH HLA-B7 HAS IMPLICATIONS FOR VACCINE DESIGN IN CERVICAL-CANCER [J].
ELLIS, JRM ;
KEATING, PJ ;
BAIRD, J ;
HOUNSELL, EF ;
RENOUF, DV ;
ROWE, M ;
HOPKINS, D ;
DUGGANKEEN, MF ;
BARTHOLOMEW, JS ;
YOUNG, LS ;
STERN, PL .
NATURE MEDICINE, 1995, 1 (05) :464-470
[8]   Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer [J].
Franco, EL ;
Villa, LL ;
Sobrinho, JP ;
Prado, JM ;
Rousseau, MC ;
Désy, M ;
Rohan, TE .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (05) :1415-1423
[9]  
Franco EL, 1997, NEW DEVELOPMENTS IN CERVICAL CANCER SCREENING AND PREVENTION, P14
[10]   Cervical cancer in older women: A molecular analysis of human papillomavirus types, HLA types, and p53 mutations [J].
Gostout, BS ;
Podratz, KC ;
McGovern, RH ;
Persing, DH .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 179 (01) :56-61